Research Paper: Identifying Adverse Drug Events: Development of a Computer-based Monitor and Comparison with Chart Review and Stimulated Voluntary Report

BACKGROUND Adverse drug events (ADEs) are both common and costly. Most hospitals identify ADEs using spontaneous reporting, but this approach lacks sensitivity; chart review identifies more events but is expensive. Computer-based approaches to ADE identification appear promising, but they have not been directly compared with chart review and they are not widely used. OBJECTIVES To develop a computer-based ADE monitor, and to compare the rate and type of ADEs found with the monitor with those discovered by chart review and by stimulated voluntary report. DESIGN Prospective cohort study in one tertiary-care hospital. PARTICIPANTS All patients admitted to nine medical and surgical units in a tertiary-care hospital over an eight-month period. MAIN OUTCOME MEASURE Adverse drug events identified by the computer-based monitor, by chart review, and by stimulated voluntary report. METHODS A computer-based monitoring program identified alerts, which were situations suggesting that an ADE might be present (e.g., an order for an antidote such as naloxone). A trained reviewer then examined patients' hospital records to determine whether an ADE had occurred. The results of the computer-based monitoring strategy were compared with two other ADE detection strategies: intensive chart review and stimulated voluntary report by nurses and pharmacists. The monitor and the chart review strategies were independent, and the reviewers were blinded. RESULTS The computer monitoring strategy identified 2,620 alerts, of which 275 were determined to be ADEs. The chart review found 398 ADEs, whereas voluntary report detected 23. Of the 617 ADEs detected by at least one method, 76 ADEs were detected by both computer monitor and chart review. The computer monitor identified 45 percent; chart review, 65 percent; and voluntary report, 4 percent. The ADEs identified by computer monitor were more likely to be classified as "severe" than were those identified by chart review (51 versus 42 percent, p = .04). The positive predictive value of computer-generated alerts was 16 percent during the first eight weeks of the study; rule modifications increased this to 23 percent in the final eight weeks. The computer strategy required 11 person-hours per week to execute, whereas chart review required 55 person-hours per week and voluntary report strategy required 5. CONCLUSIONS The computer-based monitor identified fewer ADEs than did chart review but many more ADEs than did stimulated voluntary report. The overlap among the ADEs identified using different methods was small, suggesting that the incidence of ADEs may be higher than previously reported and that different detection methods capture different events. The computer-based monitoring system represents an efficient approach for measuring ADE frequency and gauging the effectiveness of ADE prevention programs.

[1]  M Simmons,et al.  Adverse drug reactions during hospitalization. , 1968, Canadian Medical Association journal.

[2]  T. Brennan,et al.  Physician Reporting Compared with Medical-Record Review to Identify Adverse Medical Events , 1993, Annals of Internal Medicine.

[3]  H Jick,et al.  Adverse drug reactions: the magnitude of the problem. , 1984, The Journal of allergy and clinical immunology.

[4]  G. Faich,et al.  National adverse drug reaction reporting. 1984-1989. , 1991, Archives of internal medicine.

[5]  J C Russo,et al.  Medication error prevention by clinical pharmacists in two children's hospitals. , 1987, Pediatrics.

[6]  T. Brennan,et al.  The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. , 1991, The New England journal of medicine.

[7]  N. Laird,et al.  Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention , 1995 .

[8]  T H Grasela,et al.  Capability of hospital computer systems in performing drug-use evaluations and adverse drug event monitoring. , 1993, American journal of hospital pharmacy.

[9]  T. Brennan,et al.  INCIDENCE OF ADVERSE EVENTS AND NEGLIGENCE IN HOSPITALIZED PATIENTS , 2008 .

[10]  L Lasagna,et al.  Adverse drug reactions. A critical review. , 1975, JAMA.

[11]  R S Evans,et al.  Computerized surveillance of adverse drug events in hospital patients* , 1991, Quality and Safety in Health Care.

[12]  International Drug Monitoring the Role of the Hospital — A WHO Report , 1970, World Health Organization technical report series.

[13]  N. Dickey,et al.  Systems analysis of adverse drug events. , 1996, JAMA.

[14]  D. Bates,et al.  The Costs of Adverse Drug Events in Hospitalized Patients , 1997 .

[15]  G J Kuperman,et al.  Representing hospital events as complex conditionals. , 1995, Proceedings. Symposium on Computer Applications in Medical Care.

[16]  D. Bates,et al.  Systems analysis of adverse drug events. ADE Prevention Study Group. , 1995, JAMA.

[17]  R Segal,et al.  Sensitivity and specificity of three methods of detecting adverse drug reactions. , 1988, American journal of hospital pharmacy.

[18]  R F Beckley,et al.  Design of an easy-to-use physician order entry system with support for nursing and ancillary departments. , 1992, Proceedings. Symposium on Computer Applications in Medical Care.

[19]  N Hurwitz,et al.  Intensive Hospital Monitoring of Adverse Reactions to Drugs , 1969, British medical journal.

[20]  K L Melmon,et al.  Preventable drug reactions--causes and cures. , 1971, The New England journal of medicine.

[21]  M R Keith,et al.  Multidisciplinary program for detecting and evaluating adverse drug reactions. , 1989, American journal of hospital pharmacy.

[22]  G. Faich,et al.  Adverse-drug-reaction monitoring. , 1986, The New England journal of medicine.